+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bausch & Lomb Inc - Product Pipeline Analysis, 2022 Update

Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Bausch Health Companies Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as conjunctivitis, glaucoma, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Bausch & Lomb Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Bausch & Lomb Inc Company Overview
  • Bausch & Lomb Inc Company Snapshot
  • Bausch & Lomb Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Bausch & Lomb Inc - Pipeline Analysis Overview
  • Business Description
  • Bausch & Lomb Inc - Key Facts
  • Bausch & Lomb Inc - Major Products and Services
  • Bausch & Lomb Inc Pipeline Products by Development Stage
  • Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status
  • Bausch & Lomb Inc Pipeline Products Overview
  • Aqualox SiHy Daily Lens
  • Aqualox SiHy Daily Lens Product Overview
  • Bausch + Lomb Infuse Multifocal Contact Lenses
  • Bausch + Lomb Infuse Multifocal Contact Lenses Product Overview
  • BLC - 001: SVS
  • BLC - 001: SVS Product Overview
  • BLC - 002: SVS
  • BLC - 002: SVS Product Overview
  • BLC - 003: SVS/MF/fA
  • BLC - 003: SVS/MF/fA Product Overview
  • BLC - 004: Toric
  • BLC - 004: Toric Product Overview
  • BLC - 005: SVS/MF
  • BLC - 005: SVS/MF Product Overview
  • BLC - 006: SVS
  • BLC - 006: SVS Product Overview
  • BLC - 007: MF
  • BLC - 007: MF Product Overview
  • BLC - 008: Astigmatism
  • BLC - 008: Astigmatism Product Overview
  • BLC - 009: Astigmatism
  • BLC - 009: Astigmatism Product Overview
  • BLS - 001: Cataract
  • BLS - 001: Cataract Product Overview
  • BLS - 002: Cataract
  • BLS - 002: Cataract Product Overview
  • BLS - 003: Cataract
  • BLS - 003: Cataract Product Overview
  • BLS - 004: Cataract
  • BLS - 004: Cataract Product Overview
  • BLS - 005: Retina
  • BLS - 005: Retina Product Overview
  • BLS - 006: Cataract
  • BLS - 006: Cataract Product Overview
  • BLS - 007: Cataract
  • BLS - 007: Cataract Product Overview
  • BLS - 008: Cataract
  • BLS - 008: Cataract Product Overview
  • BLS - 009: Retina
  • BLS - 009: Retina Product Overview
  • BLS - 010: Cataract
  • BLS - 010: Cataract Product Overview
  • BLS - 011: Cataract
  • BLS - 011: Cataract Product Overview
  • BLS - 012: Retina
  • BLS - 012: Retina Product Overview
  • BLS - 013: Retina
  • BLS - 013: Retina Product Overview
  • BLS - 014: Refractive
  • BLS - 014: Refractive Product Overview
  • BLS - 015: Cataract
  • BLS - 015: Cataract Product Overview
  • BLS - 016: Cataract
  • BLS - 016: Cataract Product Overview
  • BLS - 018: Retina
  • BLS - 018: Retina Product Overview
  • BLS - 019: Retina
  • BLS - 019: Retina Product Overview
  • BLS - 020: Retina
  • BLS - 020: Retina Product Overview
  • BLS - 021: Retina
  • BLS - 021: Retina Product Overview
  • BLS - 022: Retina
  • BLS - 022: Retina Product Overview
  • BLS - 023: Retina
  • BLS - 023: Retina Product Overview
  • BLS - 024: Retina
  • BLS - 024: Retina Product Overview
  • BLS - 025: Retina
  • BLS - 025: Retina Product Overview
  • BLS - 026: Retina
  • BLS - 026: Retina Product Overview
  • BLS - 027: Retina
  • BLS - 027: Retina Product Overview
  • BLS - 028: Retina
  • BLS - 028: Retina Product Overview
  • BLS - 029: Retina
  • BLS - 029: Retina Product Overview
  • BLS - 030: Retina
  • BLS - 030: Retina Product Overview
  • BLS - 031: Retina
  • BLS - 031: Retina Product Overview
  • Contact Lens - Myopia
  • Contact Lens - Myopia Product Overview
  • Custom Soft Contact Lens
  • Custom Soft Contact Lens Product Overview
  • Customlens
  • Customlens Product Overview
  • enVista MX60EF Trifocal IOL
  • enVista MX60EF Trifocal IOL Product Overview
  • enVista MX60EF Trifocal IOL Clinical Trial
  • Extended Depth Of Focus Intraocular Lens
  • Extended Depth Of Focus Intraocular Lens Product Overview
  • Forge Orthokeratology Lenses
  • Forge Orthokeratology Lenses Product Overview
  • LAV - 001: Aphakia
  • LAV - 001: Aphakia Product Overview
  • LuxSmart - Toric Version
  • LuxSmart - Toric Version Product Overview
  • Next-Generation Eyetelligence
  • Next-Generation Eyetelligence Product Overview
  • Ophthalmic Viscosurgical Device
  • Ophthalmic Viscosurgical Device Product Overview
  • Ophthalmic Viscosurgical Device Clinical Trial
  • Sarfarazi Elliptical Accommodating IOL
  • Sarfarazi Elliptical Accommodating IOL Product Overview
  • TECHNOLAS TENEO 317 Excimer Laser
  • TECHNOLAS TENEO 317 Excimer Laser Product Overview
  • TECHNOLAS TENEO 317 Excimer Laser Clinical Trial
  • Ultra Plus Powers Lens
  • Ultra Plus Powers Lens Product Overview
  • XUV - 003: Aphakia
  • XUV - 003: Aphakia Product Overview
  • XUV - 004: SVS
  • XUV - 004: SVS Product Overview
  • XUV - 007: MF
  • XUV - 007: MF Product Overview
  • XUV - 009: SVS
  • XUV - 009: SVS Product Overview
  • XUV - 010: Astigmatism
  • XUV - 010: Astigmatism Product Overview
  • XUV - 011: MF
  • XUV - 011: MF Product Overview
  • XUV - 012: SVS
  • XUV - 012: SVS Product Overview
  • XUV - 013: Astigmatism
  • XUV - 013: Astigmatism Product Overview
  • XUV - 014: Presbyopia
  • XUV - 014: Presbyopia Product Overview
  • XUV - 015: MF
  • XUV - 015: MF Product Overview
  • Bausch & Lomb Inc - Key Competitors
  • Bausch & Lomb Inc - Key Employees
  • Bausch & Lomb Inc - Key Employee Biographies
  • Bausch & Lomb Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Bausch & Lomb Inc, Recent Developments
  • Jun 23, 2022: Bausch + Lomb Announces Brett Icahn and Gary Hu Have Been Appointed to its Board of Directors
  • Jun 13, 2022: Bausch + Lomb announces the U.S. Launch of Revive custom soft contact lenses
  • Jun 08, 2022: Bausch + Lomb Announces First-Quarter 2022 Results and Provides 2022 Guidance
  • May 25, 2022: Bausch + Lomb Will Release First-Quarter 2022 Financial Results on June 8
  • May 16, 2022: Bausch + Lomb Files Financial Statements for the First Quarter of 2022
  • Apr 28, 2022: Bausch + Lomb will present new scientific data and analyses on products and pipeline programs during the association for research in vision and ophthalmology meeting
  • Apr 18, 2022: Bausch + Lomb will present new scientific data during the American Society of Cataract and Refractive Surgery Annual Meeting
  • Feb 01, 2021: Prevent Blindness and Bausch + Lomb to launch year-long video series to raise awareness of age-related macular degeneration (AMD)
  • Nov 12, 2020: Bausch + Lomb reports nearly 27 million units of contact lens materials recycled through one by one recycling program
  • Apr 14, 2020: Bausch + Lomb announces publication of 10-year armor study results on ocular antibiotic resistance in JAMA Ophthalmology
  • Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Bausch & Lomb Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Bausch & Lomb Inc Pipeline Products by Equipment Type
  • Bausch & Lomb Inc Pipeline Products by Indication
  • Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status
  • Bausch & Lomb Inc, Key Facts
  • Bausch & Lomb Inc, Major Products and Services
  • Bausch & Lomb Inc Number of Pipeline Products by Development Stage
  • Bausch & Lomb Inc Pipeline Products Summary by Development Stage
  • Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status
  • Bausch & Lomb Inc Ongoing Clinical Trials Summary
  • Aqualox SiHy Daily Lens - Product Status
  • Aqualox SiHy Daily Lens - Product Description
  • Bausch + Lomb Infuse Multifocal Contact Lenses - Product Status
  • Bausch + Lomb Infuse Multifocal Contact Lenses - Product Description
  • BLC - 001: SVS - Product Status
  • BLC - 001: SVS - Product Description
  • BLC - 002: SVS - Product Status
  • BLC - 002: SVS - Product Description
  • BLC - 003: SVS/MF/fA - Product Status
  • BLC - 003: SVS/MF/fA - Product Description
  • BLC - 004: Toric - Product Status
  • BLC - 004: Toric - Product Description
  • BLC - 005: SVS/MF - Product Status
  • BLC - 005: SVS/MF - Product Description
  • BLC - 006: SVS - Product Status
  • BLC - 006: SVS - Product Description
  • BLC - 007: MF - Product Status
  • BLC - 007: MF - Product Description
  • BLC - 008: Astigmatism - Product Status
  • BLC - 008: Astigmatism - Product Description
  • BLC - 009: Astigmatism - Product Status
  • BLC - 009: Astigmatism - Product Description
  • BLS - 001: Cataract - Product Status
  • BLS - 001: Cataract - Product Description
  • BLS - 002: Cataract - Product Status
  • BLS - 002: Cataract - Product Description
  • BLS - 003: Cataract - Product Status
  • BLS - 003: Cataract - Product Description
  • BLS - 004: Cataract - Product Status
  • BLS - 004: Cataract - Product Description
  • BLS - 005: Retina - Product Status
  • BLS - 005: Retina - Product Description
  • BLS - 006: Cataract - Product Status
  • BLS - 006: Cataract - Product Description
  • BLS - 007: Cataract - Product Status
  • BLS - 007: Cataract - Product Description
  • BLS - 008: Cataract - Product Status
  • BLS - 008: Cataract - Product Description
  • BLS - 009: Retina - Product Status
  • BLS - 009: Retina - Product Description
  • BLS - 010: Cataract - Product Status
  • BLS - 010: Cataract - Product Description
  • BLS - 011: Cataract - Product Status
  • BLS - 011: Cataract - Product Description
  • BLS - 012: Retina - Product Status
  • BLS - 012: Retina - Product Description
  • BLS - 013: Retina - Product Status
  • BLS - 013: Retina - Product Description
  • BLS - 014: Refractive - Product Status
  • BLS - 014: Refractive - Product Description
  • BLS - 015: Cataract - Product Status
  • BLS - 015: Cataract - Product Description
  • BLS - 016: Cataract - Product Status
  • BLS - 016: Cataract - Product Description
  • BLS - 018: Retina - Product Status
  • BLS - 018: Retina - Product Description
  • BLS - 019: Retina - Product Status
  • BLS - 019: Retina - Product Description
  • BLS - 020: Retina - Product Status
  • BLS - 020: Retina - Product Description
  • BLS - 021: Retina - Product Status
  • BLS - 021: Retina - Product Description
  • BLS - 022: Retina - Product Status
  • BLS - 022: Retina - Product Description
  • BLS - 023: Retina - Product Status
  • BLS - 023: Retina - Product Description
  • BLS - 024: Retina - Product Status
  • BLS - 024: Retina - Product Description
  • BLS - 025: Retina - Product Status
  • BLS - 025: Retina - Product Description
  • BLS - 026: Retina - Product Status
  • BLS - 026: Retina - Product Description
  • BLS - 027: Retina - Product Status
  • BLS - 027: Retina - Product Description
  • BLS - 028: Retina - Product Status
  • BLS - 028: Retina - Product Description
  • BLS - 029: Retina - Product Status
  • BLS - 029: Retina - Product Description
  • BLS - 030: Retina - Product Status
  • BLS - 030: Retina - Product Description
  • BLS - 031: Retina - Product Status
  • BLS - 031: Retina - Product Description
  • Contact Lens - Myopia - Product Status
  • Contact Lens - Myopia - Product Description
  • Custom Soft Contact Lens - Product Status
  • Custom Soft Contact Lens - Product Description
  • Customlens - Product Status
  • Customlens - Product Description
  • enVista MX60EF Trifocal IOL - Product Status
  • enVista MX60EF Trifocal IOL - Product Description
  • enVista MX60EF Trifocal IOL - A Prospective, Multicenter, Randomized, Active-controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction
  • Extended Depth Of Focus Intraocular Lens - Product Status
  • Extended Depth Of Focus Intraocular Lens - Product Description
  • Forge Orthokeratology Lenses - Product Status
  • Forge Orthokeratology Lenses - Product Description
  • LAV - 001: Aphakia - Product Status
  • LAV - 001: Aphakia - Product Description
  • LuxSmart - Toric Version - Product Status
  • LuxSmart - Toric Version - Product Description
  • Next-Generation Eyetelligence - Product Status
  • Next-Generation Eyetelligence - Product Description
  • Ophthalmic Viscosurgical Device - Product Status
  • Ophthalmic Viscosurgical Device - Product Description
  • Ophthalmic Viscosurgical Device - Safety and Efficacy Study of a Cohesive Ophthalmic Viscosurgical Device for Use in Cataract Surgery
  • Sarfarazi Elliptical Accommodating IOL - Product Status
  • Sarfarazi Elliptical Accommodating IOL - Product Description
  • TECHNOLAS TENEO 317 Excimer Laser - Product Status
  • TECHNOLAS TENEO 317 Excimer Laser - Product Description
  • TECHNOLAS TENEO 317 Excimer Laser - A Safety and Efficacy Study of Technolas Teneo Excimer Laser for Vision Correction Surgery for Myopia and Myopic Astigmatism
  • TECHNOLAS TENEO 317 Excimer Laser - A Study to Investigate the Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia with or Without Astigmatism
  • TECHNOLAS TENEO 317 Excimer Laser - Prospective Clinical Study to Evaluate the Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment
  • Ultra Plus Powers Lens - Product Status
  • Ultra Plus Powers Lens - Product Description
  • XUV - 003: Aphakia - Product Status
  • XUV - 003: Aphakia - Product Description
  • XUV - 004: SVS - Product Status
  • XUV - 004: SVS - Product Description
  • XUV - 007: MF - Product Status
  • XUV - 007: MF - Product Description
  • XUV - 009: SVS - Product Status
  • XUV - 009: SVS - Product Description
  • XUV - 010: Astigmatism - Product Status
  • XUV - 010: Astigmatism - Product Description
  • XUV - 011: MF - Product Status
  • XUV - 011: MF - Product Description
  • XUV - 012: SVS - Product Status
  • XUV - 012: SVS - Product Description
  • XUV - 013: Astigmatism - Product Status
  • XUV - 013: Astigmatism - Product Description
  • XUV - 014: Presbyopia - Product Status
  • XUV - 014: Presbyopia - Product Description
  • XUV - 015: MF - Product Status
  • XUV - 015: MF - Product Description
  • Bausch & Lomb Inc, Key Employees
  • Bausch & Lomb Inc, Key Employee Biographies
  • Bausch & Lomb Inc, Other Locations
  • Bausch & Lomb Inc, Subsidiaries
  • Glossary
List of Figures
  • Bausch & Lomb Inc Pipeline Products by Equipment Type
  • Bausch & Lomb Inc Pipeline Products by Development Stage
  • Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • EssilorLuxottica SA
  • Harrow Health Inc
  • CooperVision Inc
  • Carl Zeiss Meditec AG
  • Abbott Medical Optics Inc
  • Johnson & Johnson Vision Care Inc